+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Companion Diagnostics"

From
From
North America In Vitro Diagnostics Market Forecast up to 2025 - Product Thumbnail Image

North America In Vitro Diagnostics Market Forecast up to 2025

  • Report
  • March 2019
  • 116 Pages
  • North America
From
Liquid Biopsy Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

Liquid Biopsy Market - Forecasts from 2021 to 2026

  • Report
  • December 2021
  • 120 Pages
  • Global
From
Tissue Diagnostics Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Tissue Diagnostics Market - Forecasts from 2023 to 2028

  • Report
  • June 2023
  • 140 Pages
  • Global
From
From
From
Companion Diagnostic Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Companion Diagnostic Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Cancer Biopsy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cancer Biopsy Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
United States Diagnostics Market Report and Forecast 2023-2031 - Product Thumbnail Image

United States Diagnostics Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 120 Pages
  • United States
From
Mexico In-vitro Diagnostics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Mexico In-vitro Diagnostics Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 150 Pages
  • Mexico
From
Loading Indicator

The Companion Diagnostics market is a subset of the biotechnology industry that focuses on the development and commercialization of diagnostic tests that are used to identify patients who are likely to benefit from a particular therapeutic. These tests are used to identify the presence of a specific biomarker or genetic mutation that is associated with a particular therapeutic. The Companion Diagnostics market is driven by the increasing demand for personalized medicine, which is tailored to the individual patient's genetic makeup. This has led to the development of more sophisticated tests that can detect a wider range of biomarkers and mutations. The Companion Diagnostics market is highly competitive, with a number of companies offering a range of tests. Examples of companies in the market include Roche Diagnostics, Abbott Laboratories, Qiagen, Illumina, and Thermo Fisher Scientific. Show Less Read more